Business Description
Jiangsu Nanfang Medical Co Ltd
ISIN : CNE100002WH0
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.14 | |||||
Debt-to-EBITDA | -4.09 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.83 | |||||
Beneish M-Score | -3.35 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -17.9 | |||||
3-Year EPS without NRI Growth Rate | -111.4 | |||||
3-Year Book Growth Rate | -12.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 91.79 | |||||
9-Day RSI | 82.36 | |||||
14-Day RSI | 75.11 | |||||
6-1 Month Momentum % | -15.71 | |||||
12-1 Month Momentum % | -23.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.8 | |||||
Quick Ratio | 0.44 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 203.25 | |||||
Days Sales Outstanding | 109.09 | |||||
Days Payable | 173.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.4 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8.12 | |||||
Operating Margin % | -7.45 | |||||
Net Margin % | -28.1 | |||||
FCF Margin % | 6.77 | |||||
ROE % | -29.01 | |||||
ROA % | -11.43 | |||||
ROIC % | -3.23 | |||||
3-Year ROIIC % | -29.22 | |||||
ROC (Joel Greenblatt) % | -17.57 | |||||
ROCE % | -23.26 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 39.92 | |||||
PS Ratio | 2.08 | |||||
PB Ratio | 2.59 | |||||
Price-to-Tangible-Book | 2.82 | |||||
Price-to-Free-Cash-Flow | 23.43 | |||||
Price-to-Operating-Cash-Flow | 10.61 | |||||
EV-to-EBIT | -12.14 | |||||
EV-to-EBITDA | -12.14 | |||||
EV-to-Revenue | 2.89 | |||||
EV-to-FCF | 42.67 | |||||
Earnings Yield (Greenblatt) % | -8.24 | |||||
FCF Yield % | 3.09 | |||||
Forward Rate of Return (Yacktman) % | -4.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jiangsu Nanfang Medical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 549.098 | ||
EPS (TTM) (Â¥) | -0.536 | ||
Beta | 0.71 | ||
Volatility % | 37.12 | ||
14-Day RSI | 75.11 | ||
14-Day ATR (Â¥) | 0.164241 | ||
20-Day SMA (Â¥) | 3.544 | ||
12-1 Month Momentum % | -23.87 | ||
52-Week Range (Â¥) | 3.08 - 5.38 | ||
Shares Outstanding (Mil) | 289.04 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jiangsu Nanfang Medical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jiangsu Nanfang Medical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Jiangsu Nanfang Medical Co Ltd Frequently Asked Questions
What is Jiangsu Nanfang Medical Co Ltd(SHSE:603880)'s stock price today?
When is next earnings date of Jiangsu Nanfang Medical Co Ltd(SHSE:603880)?
Does Jiangsu Nanfang Medical Co Ltd(SHSE:603880) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |